These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 10998463)

  • 1. Effect of atorvastatin and fluvastatin on the expression of plasminogen activator inhibitor type-1 in cultured human endothelial cells.
    Lopez S; Peiretti F; Bonardo B; Juhan-Vague I; Nalbone G
    Atherosclerosis; 2000 Oct; 152(2):359-66. PubMed ID: 10998463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluvastatin inhibits basal and stimulated plasminogen activator inhibitor 1, but induces tissue type plasminogen activator in cultured human endothelial cells.
    Mussoni L; Banfi C; Sironi L; Arpaia M; Tremoli E
    Thromb Haemost; 2000 Jul; 84(1):59-64. PubMed ID: 10928471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of atorvastatin on plasminogen activator inhibitor type-1 synthesis in human monocytes/macrophages.
    Lopez S; Peiretti F; Bonardo B; Deprez-Beauclair P; Laouenan H; Juhan-Vague I; Nalbone G
    J Cardiovasc Pharmacol; 2001 Jun; 37(6):762-8. PubMed ID: 11392473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3-hydroxy-3-methylglutaryl coenzyme A reductase-independent inhibition of CD40 expression by atorvastatin in human endothelial cells.
    Wagner AH; Gebauer M; Güldenzoph B; Hecker M
    Arterioscler Thromb Vasc Biol; 2002 Nov; 22(11):1784-9. PubMed ID: 12426205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of the endothelial plasminogen activator system by fluvastatin. Role of Rho family proteins, actin polymerisation and p38 MAP kinase.
    Dunoyer-Geindre S; Fish RJ; Kruithof EK
    Thromb Haemost; 2011 Mar; 105(3):461-72. PubMed ID: 21174002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins prevent endothelial cell activation induced by antiphospholipid (anti-beta2-glycoprotein I) antibodies: effect on the proadhesive and proinflammatory phenotype.
    Meroni PL; Raschi E; Testoni C; Tincani A; Balestrieri G; Molteni R; Khamashta MA; Tremoli E; Camera M
    Arthritis Rheum; 2001 Dec; 44(12):2870-8. PubMed ID: 11762948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HMG CoA reductase inhibitors affect the fibrinolytic system of human vascular cells in vitro: a comparative study using different statins.
    Wiesbauer F; Kaun C; Zorn G; Maurer G; Huber K; Wojta J
    Br J Pharmacol; 2002 Jan; 135(1):284-92. PubMed ID: 11786505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in the fibrinolytic components of cultured human umbilical vein endothelial cells induced by endotoxin, tumor necrosis factor-alpha and interleukin-1alpha.
    Orbe J; Chordá C; Montes R; Páramo JA
    Haematologica; 1999 Apr; 84(4):306-11. PubMed ID: 10190943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of fluvastatin on fibrinolytic factors in patients with hypercholesterolemia.
    Lin TH; Huang CH; Voon WC; Yen HW; Lai HM; Liang HY; Lu YH; Lee KT; Lee CS; Lai WT; Sheu SH
    Kaohsiung J Med Sci; 2000 Dec; 16(12):600-6. PubMed ID: 11392099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodynamic forces modulate the effects of cytokines on fibrinolytic activity of endothelial cells.
    Kawai Y; Matsumoto Y; Watanabe K; Yamamoto H; Satoh K; Murata M; Handa M; Ikeda Y
    Blood; 1996 Mar; 87(6):2314-21. PubMed ID: 8630393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HMG-CoA reductase inhibitors regulate inflammatory transcription factors in human endothelial and vascular smooth muscle cells.
    Dichtl W; Dulak J; Frick M; Alber HF; Schwarzacher SP; Ares MP; Nilsson J; Pachinger O; Weidinger F
    Arterioscler Thromb Vasc Biol; 2003 Jan; 23(1):58-63. PubMed ID: 12524225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluvastatin reduces endothelin secretion of cultured human umbilical vein endothelial cells.
    Mueck AO; Seeger H; Lippert TH
    Eur J Clin Pharmacol; 1999 Nov; 55(9):625-6. PubMed ID: 10638389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of statins on mRNA levels of genes related to inflammation, coagulation, and vascular constriction in HUVEC. Human umbilical vein endothelial cells.
    Morikawa S; Takabe W; Mataki C; Kanke T; Itoh T; Wada Y; Izumi A; Saito Y; Hamakubo T; Kodama T
    J Atheroscler Thromb; 2002; 9(4):178-83. PubMed ID: 12226549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A HMG-CoA reductase inhibitor possesses a potent anti-atherosclerotic effect other than serum lipid lowering effects--the relevance of endothelial nitric oxide synthase and superoxide anion scavenging action.
    Sumi D; Hayashi T; Thakur NK; Jayachandran M; Asai Y; Kano H; Matsui H; Iguchi A
    Atherosclerosis; 2001 Apr; 155(2):347-57. PubMed ID: 11254905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atorvastatin inhibition of cytokine-inducible nitric oxide synthase expression in native endothelial cells in situ.
    Wagner AH; Schwabe O; Hecker M
    Br J Pharmacol; 2002 May; 136(1):143-9. PubMed ID: 11976279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statins and fenofibrate affect skeletal muscle chloride conductance in rats by differently impairing ClC-1 channel regulation and expression.
    Pierno S; Camerino GM; Cippone V; Rolland JF; Desaphy JF; De Luca A; Liantonio A; Bianco G; Kunic JD; George AL; Conte Camerino D
    Br J Pharmacol; 2009 Apr; 156(8):1206-15. PubMed ID: 19220292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statins upregulate cystathionine γ-lyase transcription and H2S generation via activating Akt signaling in macrophage.
    Xu Y; Du HP; Li J; Xu R; Wang YL; You SJ; Liu H; Wang F; Cao YJ; Liu CF; Hu LF
    Pharmacol Res; 2014 Sep; 87():18-25. PubMed ID: 24951966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of TNFalpha-induced IL-1alpha, IL-1beta and IL-6 expression in human cardiac fibroblasts: effects of statins and thiazolidinediones.
    Turner NA; Mughal RS; Warburton P; O'Regan DJ; Ball SG; Porter KE
    Cardiovasc Res; 2007 Oct; 76(1):81-90. PubMed ID: 17612514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of atorvastatin, fluvastatin, pravastatin, and simvastatin on endothelial function, lipid peroxidation, and aortic atherosclerosis in hypercholesterolemic rabbits].
    Jorge PA; Almeida EA; Ozaki MR; Jorge M; Carneiro A
    Arq Bras Cardiol; 2005 Apr; 84(4):314-9. PubMed ID: 15880205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerivastatin, a HMG-CoA reductase inhibitor, reduces plasminogen activator inhibitor-1 (PAI-1) expression in endothelial cells by down-regulation of cellular signaling and the inhibition of PAI-1 promoter activity.
    Swiatkowska M; Pawlowska Z; Szemraj J; Drzewoski J; Watala C; Cierniewski CS
    Jpn J Pharmacol; 2002 Dec; 90(4):337-44. PubMed ID: 12501010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.